XML 42 R30.htm IDEA: XBRL DOCUMENT v3.22.2
Reverse Recapitalization - Narrative (Details)
 1 Months Ended 6 Months Ended
Jun. 09, 2021
USD ($)
$ / shares
shares
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
shares
Jun. 30, 2021
USD ($)
Dec. 31, 2021
shares
Jun. 08, 2021
shares
Schedule Of Reverse Recapitalization [Line Items]            
Stock converted, value, reverse recapitalization $ 900,000,000          
Recapitalization exchange ratio, per share (in dollars per share) | $ / shares $ 10.00          
Recapitalization exchange ratio 3.6281   3.6281      
Common stock, shares outstanding (in shares) | shares 124,045,255   124,562,745   124,303,083  
Stock converted, reverse recapitalization (in shares) | shares 85,324,118          
Equity value $ 900,000,000          
Stock options issued and outstanding (in shares) | shares 7,106,767   11,650,794   8,550,076  
Net proceeds from reverse recapitalization and PIPE financing $ 335,400,000   $ 0 $ 335,409,000    
Cash acquired through reverse recapitalization 135,400,000          
Reverse recapitalization, cash paid to shareholders 10,100,000          
Gross proceeds from private placement 200,000,000          
Payments of transaction costs $ 8,100,000 $ 18,200,000        
Private Placement            
Schedule Of Reverse Recapitalization [Line Items]            
Shares issued in transaction (in shares) | shares 20,000,000          
Consideration received on transaction $ 200,000,000          
Arya Sciences Acquisition Corp III            
Schedule Of Reverse Recapitalization [Line Items]            
Common stock, shares outstanding (in shares) | shares 18,721,137         19,186,500
Options            
Schedule Of Reverse Recapitalization [Line Items]            
Stock converted, value, reverse recapitalization $ 24,300,000